Seeing the Excitement of Aesthetic Doctors with PYFAESTHETIC Taking Cadaver Training to Korea
Jakarta, 26 Juli 2023 – PYFASTHETIC, bisnis unit dari PT Pyridam Farma Tbk kembali mengadakan program Cadaver Training “PYFAESTHETIC goes
Tips to help overcome your little one’s persistent cough and flu
Jakarta, 14 July 2023 – In the last few months, air quality in Indonesia, especially in Jakarta, has fallen into
PYFAESTHETIC Successfully Holds Cadaver Training to South Korea
Jakarta, 4 April 2023 – PYFAESTHETIC, a subsidiary of PT Pyridam Farma Tbk (PYFA) engaged in the field of dermatology
Pyridam Farma Participates in Health Interactive Dialogue Safe Drug Syrup
Jakarta, 21 March 2023 – Pyridam Farma participated in an interactive health dialogue “Safe drug syrup” with the Association of
Continuing to Expansion & Innovation, Pyridam Farma Officially Acquires PT Ethica Industri Pharmacy
Yenfrino Gunadi (Director of Pyridam Farma), Bedjo Stefanus (SVP of Pyridam Farma), Lee Yan Gwan (President Director of Pyridam Farma),
Pyridam Farma (PYFA) Presents an AI-Based Cervix Cancer Screening Tool, Cerviray A.I.
Jakarta, 15 July 2022 – Pyridam Farma (PYFA) together with AIDOT Inc. will soon present innovative healthcare products for the
More Expansion! PT Pyridam Farma Tbk (PYFA) Acquisition of PT Ethica Industri Pharmaceuticals
Jakarta, 13 June 2022 – After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam
Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Jakarta, May 6, 2022 – PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net
Mundipharma Healthcare Indonesia Appoints Pyridam Farma to Market Betadine Brand in Indonesia
Jakarta, April 5, 2022 – Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an
Merz Therapeutics GmbH Together with Pyridam Farma Presents Innovative Products for the Indonesian Community
Jakarta, 22 March 2022 – Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with